O'HoraA, MoraJ, HIV in Ireland, 2011 in Brief. HPSC Report (Ireland). http://www.hpsc.ie/hpsc/A-Z/HIVSTIs/HIVandAIDS/SurveillanceReports/File,13069,en.pdf. (Last accessed November19, 2013.)
2.
GiordanoTP, GiffordAL, WhiteACJr, et al. Retention in care: A challenge to survival with HIV infection. Clin Infect Dis, 2007; 44:1493–1499.
3.
AntelmanG, Smith FawziMC, KaayaS, et al. Predictors of HIV-1 serostatus disclosure: A prospective study among HIV-infected pregnant women in Dar es Salaam, Tanzania. AIDS, 2001; 15:1865–1874.
4.
KoeghP, AllenS, AlmedalC, TemahagaliB. (1994) The social impact of HIV infection on women in Kigali, Rwanda: A prospective study. Soc Sci Med, 1994; 38:1047–1053.
5.
SmithL, FisherJ, CunninghamC, AmicoK. Understanding the behavioral determinants of retention in HIV care: A qualitative evaluation of a situated information, motivation, behavioral skills model of care initiation and maintenance. AIDS Patient Care STDs, 2012, DOI: 10.1089/apc.2011.0388.
6.
AriciC, RipamontiD, MaggioloF, et al. Unità Operativa di Malattie Infettive, Ospedali Riuniti di Bergamo, Largo Barozzi, Bergamo, Italy. aricirm@tin.it Factors associated with the failure of HIV-positive persons to return for scheduled medical visits. HIV Clin Trials, 2002; 3:52–57.
7.
BrettleRP, GoreSM, McNeilA. Outpatient medical care of injection drug use related HIV. Regional Infectious Disease Unit, City Hospital, Edinburgh, UK. Int J STD AIDS, 1992; 3:96–100.
8.
KreitchmannR, HarrisR, KakehasiF, et al. for the NISDI LILAC Study Team. Antiretroviral adherence during pregnancy and postpartum in Latin America. AIDS Patient Care STDs, 2012; 26:486.
9.
Research Programme on “Health Services, Health Inequalities and Health and Social Gain”. A Comparison of GP Visiting in Northern Ireland and The Republic of Ireland, Working Paper 22, School of Economics and Politics, University of Ulster, Northern Ireland. Economic and Social Research Institute, Dublin, Ireland.
10.
FergusonW, GoodeM, WalshA, GavinP, ButlerK. Evaluation of 4 weeks' neonatal antiretroviral prophylaxis as a component of a prevention of mother-to-child transmission program in a resource-rich setting. Pediatr Infect Dis J, 2011; 30:408–412.
11.
MelekhinVV, ShepherdBE, JenkinsCA, et al. Postpartum discontinuation of antiretroviral therapy and risk of maternal AIDS-defining events, non-AIDS-defining events, and mortality among a cohort of HIV-1-infected women in the United States. AIDS Patient Care STDS, 2010; 24:279–286.
